Clinical and epidemiological aspects of complicated malaria in Colombia, 2007-2013

Malaria Journal

Volumn 15, Issue 1, 2016, Pages

  Chaparro Narváez, Pablo E ^a   Lopez Perez, Mary ^b   Rengifo, Lina Marcela ^b   Padilla, Julio ^c   Herrera, Sócrates ^b   Arévalo Herrera, Myriam ^b,d  

^a INSTITUTO NACIONAL DE SALUD   (Colombia)

^b Caucaseco Scientific Research Center   (Colombia)

^c Ministry of Social Protection   (Colombia)

^d UNIVERSIDAD DEL VALLE   (Colombia)

Author keywords

Colombia; Complicated malaria; Malaria surveillance; Plasmodium falciparum; Plasmodium vivax

Indexed keywords

ANTIMALARIAL AGENT;

ADOLESCENT; ADULT; AGED; ANEMIA; BRAIN DISEASE; CHILD; CHILL; CLINICAL FEATURE; COLOMBIA; CONFUSION; DEATH; DESCRIPTIVE RESEARCH; DISEASE SEVERITY; FEMALE; FEVER; GROUPS BY AGE; HEADACHE; HEPATOMEGALY; HUMAN; INFANT; JAUNDICE; KIDNEY DISEASE; LUNG DISEASE; MAJOR CLINICAL STUDY; MALARIA; MALE; MIXED INFECTION; MYALGIA; NONHUMAN; PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; PRESCHOOL CHILD; REVIEW; SEX DIFFERENCE; SHOCK; SOMNOLENCE; YOUNG ADULT; COMPLICATION; DEMOGRAPHY; KIDNEY DISEASES; LIVER DISEASES; LUNG DISEASES; MALARIA, FALCIPARUM; MALARIA, VIVAX; MIDDLE AGED; NEWBORN; PATHOLOGY; PREVALENCE;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; COLOMBIA; DEMOGRAPHY; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; KIDNEY DISEASES; LIVER DISEASES; LUNG DISEASES; MALARIA, FALCIPARUM; MALARIA, VIVAX; MALE; MIDDLE AGED; PREVALENCE; YOUNG ADULT;

EID: 84969143107     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/s12936-016-1323-5     Document Type: Review

References (42)

1. WHO. World Malaria Report 2015. Geneva: World Health Organization; 2015. p. 280.
2. Miller LH, Baruch DI, Marsh K, Doumbo OK. The pathogenic basis of malaria. Nature. 2002;415:673-9.
3. Langhorne J, Ndungu FM, Sponaas AM, Marsh K. Immunity to malaria: more questions than answers. Nat Immunol. 2008;9:725-32.
4. Doolan DL, Dobano C, Baird JK. Acquired immunity to malaria. Clin Microbiol Rev. 2009;22:13-36.
5. Bousema T, Okell L, Felger I, Drakeley C. Asymptomatic malaria infections: detectability, transmissibility and public health relevance. Nat Rev Microbiol. 2014;12:833-40.
6. Arevalo-Herrera M, Lopez-Perez M, Medina L, Moreno A, Gutierrez JB, Herrera S. Clinical profile of Plasmodium falciparum and Plasmodium vivax infections in low and unstable malaria transmission settings of Colombia. Malar J. 2015;14:154.
7. Rodriguez JC, Uribe GA, Araujo RM, Narvaez PC, Valencia SH. Epidemiology and control of malaria in Colombia. Mem Inst Oswaldo Cruz. 2011;106(Suppl 1):114-22.
8. Gonzalez LM, Guzman M, Carmona J, Lopera T, Blair S. Clinical and epidemiologic characteristics of 291 hospitalized patients for malaria in Medellin (Colombia). Acta Med Colomb. 2000;25:163-70 (in Spanish).
9. Arboleda M, Perez MF, Fernandez D, Usuga LY, Meza M. Clinical and laboratory profile of Plasmodium vivax malaria patients hospitalized in Apartado, Colombia. Biomedica. 2012;32(Suppl 1):58-67 (in Spanish).
10. Tobon A, Giraldo C, Pineros-Jimenez JG, Arboleda M, Blair S, Carmona-Fonseca J. The epidemiology of complicated falciparum malaria: case and controls study in Tumaco and Turbo, Colombia, 2003. Rev Bras Epidemiol. 2006;9:283-96 (in Spanish).
11. Tobon-Castano A, Giraldo-Castro C, Blair S. Prognostic value of clinical and parasitological signs for severe malaria in patients from Colombia. Biomedica. 2012;32(Suppl 1):79-94 (in Spanish).
12. Medina-Morales DA, Montoya-Franco E, Sanchez-Aristizabal VD, Machado-Alba JE, Rodriguez-Morales AJ. Severe and benign Plasmodium vivax malaria in Embera (Amerindian) children and adolescents from an endemic municipality in Western Colombia. J Infect Public Health. 2016;9:172-80.
13. O'Brien AT, Ramirez JF, Martinez SP. A descriptive study of 16 severe Plasmodium vivax cases from three municipalities of Colombia between 2009 and 2013. Malar J. 2014;13:404.
14. Piñeros-Jiménez JG, Arboleda M, Jaramillo JC, Blair S. Report of five cases of severe neonatal Plasmodium vivax malaria in Uraba, Colombia. Biomedica. 2008;28:471-9 (in Spanish).
15. WHO. Severe falciparum malaria. World Health Organization, communicable diseases cluster. Trans R Soc Trop Med Hyg. 2000;94(Suppl 1):1-90.
16. Chaparro P, Padilla J, Vallejo AF, Herrera S. Characterization of a malaria outbreak in Colombia in 2010. Malar J. 2013;12:330.
17. Pineros-Jimenez JG, Arboleda M, Jaramillo JC, Blair S. Report of five cases of severe neonatal Plasmodium vivax malaria in Uraba, Colombia. Biomedica. 2008;28:471-9.
18. Martínez-Salazar EL, Tobón-Castaño A. Platelet profile is associated with clinical complications in patients with vivax and falciparum malaria in Colombia. Rev Soc Bras Med Trop. 2014;47:341-9.
19. Pineros JG, Tobon-Castano A, Alvarez G, Portilla C, Blair S. Maternal clinical findings in malaria in pregnancy in a region of northwestern Colombia. Am J Trop Med Hyg. 2013;89:520-6.
20. López ML, Arango EM, Arias LR, Carmona-Fonseca J, Blair S. Intraleucocytic hemozoine as an indicator malaria complicated by Plasmodium falciparum. Acta Méd Colomb. 2004;29:80-7 (in Spanish).
21. MinSalud. Ministerio de la Protección Social. Colombia. Guía de atención clínica de malaria Ministerio de la Protección Social, Bogotá. 2010. p. 132.
22. INS. Protocolo para la vigilancia en salud pública de malaria. http://www.ins.gov.co/temas-de-interes/Documentacin%20Malaria/01%20Protocolo%20Malaria.pdf. Accessed 28 Aug 2015.
23. Carter KH, Singh P, Mujica OJ, Escalada RP, Ade MP, Castellanos LG, et al. Malaria in the Americas: trends from 1959 to 2011. Am J Trop Med Hyg. 2015;92:302-16.
24. DANE. Series de población 1985-2020. Colombia. http://www.dane.gov.co/index.php/poblacion-y-demografia/series-de-poblacion. Accessed 5 Feb 2015.
25. Rodriguez-Morales AJ, Benitez JA, Arria M. Malaria mortality in Venezuela: focus on deaths due to Plasmodium vivax in children. J Trop Pediatr. 2008;54:94-101.
26. Quispe AM, Pozo E, Guerrero E, Durand S, Baldeviano GC, Edgel KA, et al. Plasmodium vivax hospitalizations in a monoendemic malaria region: severe vivax malaria? Am J Trop Med Hyg. 2014;91:11-7.
27. Lacerda MV, Mourao MP, Alexandre MA, Siqueira AM, Magalhaes BM, Martinez-Espinosa FE, et al. Understanding the clinical spectrum of complicated Plasmodium vivax malaria: a systematic review on the contributions of the Brazilian literature. Malar J. 2012;11:12.
28. Rahimi BA, Thakkinstian A, White NJ, Sirivichayakul C, Dondorp AM, Chokejindachai W. Severe vivax malaria: a systematic review and meta-analysis of clinical studies since 1900. Malar J. 2014;13:481.
29. Arévalo-Herrera M, Soto L, Perlaza BL, Céspedes N, Vera O, Lenis AM, et al. Antibody-mediated and cellular immune responses induced in naive volunteers by vaccination with long synthetic peptides derived from the Plasmodium vivax circumsporozoite protein. Am J Trop Med Hyg. 2011;84:35-42.
30. Price RN, Tjitra E, Guerra CA, Yeung S, White NJ, Anstey NM. Vivax malaria: neglected and not benign. Am J Trop Med Hyg. 2007;77:79-87.
31. Anstey NM, Russell B, Yeo TW, Price RN. The pathophysiology of vivax malaria. Trends Parasitol. 2009;25:220-7.
32. Carvalho BO, Lopes SC, Nogueira PA, Orlandi PP, Bargieri DY, Blanco YC, et al. On the cytoadhesion of Plasmodium vivax-infected erythrocytes. J Infect Dis. 2010;202:638-47.
33. Lopes SC, Albrecht L, Carvalho BO, Siqueira AM, Thomson-Luque R, Nogueira PA, et al. Paucity of Plasmodium vivax mature schizonts in peripheral blood is associated with their increased cytoadhesive potential. J Infect Dis. 2014;209:1403-7.
34. De las Salas B, Segura C, Pabon A, Lopes SC, Costa FT, Blair S. Adherence to human lung microvascular endothelial cells (HMVEC-L) of Plasmodium vivax isolates from Colombia. Malar J. 2013;12:347.
35. Leal-Santos FA, Silva SB, Crepaldi NP, Nery AF, Martin TO, Alves-Junior ER, et al. Altered platelet indices as potential markers of severe and complicated malaria caused by Plasmodium vivax: a cross-sectional descriptive study. Malar J. 2013;12:462.
36. Pinzon MA, Pineda JC, Rosso F, Shinchi M, Bonilla-Abadia F. Plasmodium vivax cerebral malaria complicated with venous sinus thrombosis in Colombia. Asian Pac J Trop Med. 2013;6:413-5.
37. Luxemburger C, Ricci F, Nosten F, Raimond D, Bathet S, White NJ. The epidemiology of severe malaria in an area of low transmission in Thailand. Trans R Soc Trop Med Hyg. 1997;91:256-62.
38. Mayxay M, Pukrittayakamee S, Newton PN, White NJ. Mixed-species malaria infections in humans. Trends Parasitol. 2004;20:233-40.
39. Price RN, Simpson JA, Nosten F, Luxemburger C, Hkirjaroen L, ter Kuile F, et al. Factors contributing to anemia after uncomplicated falciparum malaria. Am J Trop Med Hyg. 2001;65:614-22.
40. Kochar DK, Das A, Kochar A, Middha S, Acharya J, Tanwar GS, et al. A prospective study on adult patients of severe malaria caused by Plasmodium falciparum, Plasmodium vivax and mixed infection from Bikaner, northwest India. J Vector Borne Dis. 2014;51:200-10.
41. Lopez-Perez M, Alvarez A, Gutierrez JB, Moreno A, Herrera S, Arevalo-Herrera M. Malaria-related anemia in patients from unstable transmission areas in Colombia. Am J Trop Med Hyg. 2015;92:294-301.
42. WHO. Severe malaria. Trop Med Int Health. 2014;19(Suppl 1):7-131.